{"database": "lobbying", "table": "lobbying_activities", "rows": [[2861782, "73f1833c-1eac-47c2-808d-ec67391ee782", "4T", "ANDREW VOGT STRATEGIES LLC", 401106004, "ALLIANCE FOR CELL THERAPY NOW", 2022, "fourth_quarter", "BUD", "Increased funding for research on regenerative medicine and cell therapies at the National Institutes of Health and Department of Health and Human Services; Implementation of the 21st Century Cures Act", "Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE", 0, 1, "2022-10-10T09:58:56-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2861782"], "units": {}, "query_ms": 0.2197630237787962, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}